Skip to content
RDL Network logo
Elucidating the cardiac outcomes of irreversible proteasome inhibitor Carfilzomib in in vivo models of HFpEF and HFrEF. Preventive role of Metformin — Panagiotis Efentakis (2022) | RDL Network